Federal contractors / NEXTGEN FEDERAL SYSTEMS LLC

Federal contract award

47QFCA23F0033

ASTEROID

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyGeneral Services Administration
OfficeGSA FAS AAS FEDSIM
NAICS541330 — Engineering Services
PSCR425 — Engineering and Technical Services
Parent award / vehicle47QRAD20D3166
Set-asideSMALL BUSINESS SET ASIDE - TOTAL
Pricing typeCOST PLUS AWARD FEE
Obligations$56.3M
Current contract value$133.0M
Potential contract value / ceiling$169.8M
Start dateJul 17, 2023
Current end dateJul 16, 2027
Potential end dateJul 16, 2028
Latest award activitySep 4, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 60 of 60 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Sep 4, 2026P00059$138.2KASTEROID. THE PURPOSE OF THIS MODIFICATION WAS TO PROVIDE INCREMENTAL FUNDING AND ADMINISTRATIVE UPDATE FOR THE REQUIREMENT.
Aug 20, 2026P00058$1.4MASTEROID. THE PURPOSE OF THE MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING FOR THE REQUIREMENT.
Jul 22, 2026P00057$1.2MASTEROID. THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING AND ADMINISTRATIVE UPDATES.
Jul 10, 2026P00056$1.6MASTEROID. THE PURPOSE OF THE MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING AND ADMINISTRATIVE UPDATES.
Jun 10, 2026P00055$860.5KASTEROID. THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE ADMINISTRATIVE UPDATES AND INCREMENTAL FUNDING.
Jun 2, 2026P00054$0ASTEROID. THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE EXERCISE OF OY3 AND INCREMENTAL FUNDING.
May 14, 2026P00053$575.6KASTEROID. THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING FOR THE REQUIREMENT. E.O. 14398
May 7, 2026P00052$714.9KASTEROID. THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING AND ADMINISTRATIVE UPDATES. (EO 14398)
Apr 14, 2026P00051$195.1KASTEROID. THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING FOR THE REQUIREMENT.
Mar 27, 2026P00050$341.5KASTEROID. THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING FOR THE REQUIREMENT.
Mar 13, 2026P00049$2.0MASTEROID. THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING AND ADMINISTRATIVE UPDATES FOR THE REQUIREMENT.
Feb 27, 2026P00048$207.5KASTEROID. THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING AND ADMINISTRATIVE UPDATES FOR THE REQUIREMENT.
Feb 17, 2026P00047$736.7KASTEROID. THE PURPOSE OF THE MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING FOR THE REQUIREMENT.
Feb 2, 2026P00046$364.2KASTEROID. THE PURPOSE OF THE MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING FOR THE REQUIREMENT.
Dec 30, 2025P00045$929.1KASTEROID - THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING AND ADMINISTRATIVE UPDATES.
Dec 19, 2025P00044$175.6KASTEROID
Dec 10, 2025P00043$518.7KASTEROID - THE PURPOSE OF THE MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING AND ADMINISTRATIVE UPDATE FOR THE REQUIREMENT.
Nov 26, 2025P00042$1.4MASTEROID. THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING AND ADMINISTRATIVE UPDATES FOR THE REQUIREMENT.
Nov 18, 2025P00041$293.7KASTEROID - THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE ADMINISTRATIVE REALIGNMENT OF FUNDING.
Nov 7, 2025P00040$0ASTEROID
Sep 30, 2025P00039$3.8MASTEROID
Sep 23, 2025P00038$-62.7KASTEROID
Sep 8, 2025P00037$1.1MASTEROID
Aug 7, 2025P00036$712.7KASTEROID
Jul 10, 2025P00035$1.9MTHE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE FUNDS, REALLOCATE FUNDS AND EXERCISE OPTION PERIOD 2.
Jun 10, 2025P00034$465.9KTHE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING.
May 19, 2025P00033$1.2MINCREMENTAL FUNDING MODIFICATION
Apr 24, 2025P00032$723.6KASTEROID
Mar 19, 2025P00031$324.0KASTEROID
Feb 27, 2025P00030$2.7MASTEROID
Jan 15, 2025P00029$502.0KASTEROID
Dec 18, 2024P00028$239.8KASTEROID
Nov 25, 2024P00027$3.7MASTEROID
Oct 29, 2024P00026$-406.7KASTEROID
Sep 25, 2024P00025$795.3KASTEROID
Sep 9, 2024P00024$1.9MASTEROID
Aug 29, 2024P00023$2.1MASTEROID
Aug 9, 2024P00022$23.0KASTEROID
Jul 25, 2024P00021$462.4KASTEROID
Jul 19, 2024P00020$2.9MASTEROID
Jul 12, 2024P00019$-1.1MASTEROID
Jul 3, 2024P00018$659.3KASTEROID
Jun 24, 2024P00017$576.3KASTEROID
May 29, 2024P00016$-50.1KASTEROID
May 6, 2024P00015$19.5KASTEROID
Apr 10, 2024P00014$1.5MASTEROID
Mar 27, 2024P00013$2.1MASTEROID
Mar 7, 2024P00012$-1.4MASTEROID
Feb 26, 2024P00011$127.0KASTEROID
Feb 14, 2024P00010$1.5MTHE PURPOSE OF THIS MODIFICATION IS TO REALIGN CEILING AND REALLOCATE FUNDS.
Jan 31, 2024P00009$2.2MASTEROID
Jan 9, 2024P00008$1.4MASTEROID
Dec 5, 2023P00007$2.6MASTEROID
Oct 17, 2023P00006$0ASTEROID
Sep 26, 2023P00005$821.0KASTEROID
Aug 30, 2023P00004$183.8KASTEROID
Aug 17, 2023P00003$1.4MASTEROID
Jul 28, 2023P00002$3.3MASTEROID
Jul 25, 2023P00001$0ASTEROID
Jun 29, 20230$1.4MASTEROID

Estimated positioning window

Jul 16, 2027 – Jan 16, 2028

Recompete signal:
75/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 75/100. Available recorded signals: 70 points.

Contract end 2028-07-16 (630 days from calculation)
+25 points
53 historical awards in this buyer and category group
+15 points
60 recorded award transactions
+10 points
Latest award action: 2026-09-04
+5 points
Parent award identifier recorded
+5 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-10-25 10:18:04.631876+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Oct 25, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Verify whether remaining options may extend performance beyond the current end date.
  3. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  4. Check the stated set-aside against the solicitation and current certifications.
  5. Review the award scope and buyer evidence before making a bid/no-bid decision.